OPS — Opsens Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- CA$334.82m
- CA$325.92m
- CA$48.35m
Brief: Opsens Announces Second Quarter Fiscal 2022 Results
Brief: Opsens Announces Abiomed 4-Year Supply Agreement Extension To 2028
Brief: Opsens Announces First Quarter Fiscal 2022 Financial Results
Brief: Opsens Announces 510(K) Submission To U.S. FDA For New Guidewire For The Tavr Procedure
Brief: Opsens Q4 Revenue Rises 7% to C$8.1 Mln
Brief: Opsens Successfully Completes 20-Patient In Study For TAVR Procedure
Brief: Opsens Receives Approval From Health Canada To Initiate First In-Man Clinical Study For New Guidewire For TAVR Procedure
Brief: Opsens Announces Q3 Results
Brief: OpSens Solutions Receives Funding to Jointly Develop Optical-Based Fuel Monitoring System for Aerospace Applications
Brief: Opsens Announces Q2 Fiscal 2021 Financial Results And Record Ffr And Dpr Revenues
Brief: OpSens Obtains CE Marking For OptoWire III
Brief: OpSens Inc Announces $25 Million Bought Deal Offering
Canada Research Roundup: Aritzia, Finning International, First Quantum Minerals
Brief: Opsens Announces First Quarter Fiscal 2021 Financial Results
Brief: OpSens Announces Fourth Quarter And Fiscal Year 2020 Financial Results
Canada Research Roundup: Docebo, Enghouse Systems, Kinaxis
Brief: Opsens Inc Posts Q3 Net Earnings Of $0.1 Mln
Canada Research Roundup: Autocanada, Bombardier, Saputo
Brief: Opsens Inc - Exempt From Quebec Province Order To Close Non-Essential Businesses Until April 13